News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
847,484 Results
Type
Article (86528)
Company Profile (702)
Press Release (760254)
Multimedia
Podcasts (131)
Webinars (14)
Section
Business (232699)
Career Advice (4128)
Deals (39721)
Drug Delivery (129)
Drug Development (90992)
Employer Resources (198)
FDA (18114)
Job Trends (17341)
News (396497)
Policy (39755)
Tag
Academia (3000)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (96)
Alliances (56842)
ALS (106)
Alzheimer's disease (1507)
Antibody-drug conjugate (ADC) (164)
Approvals (18070)
Artificial intelligence (338)
Autoimmune disease (30)
Automation (17)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (481)
Bladder cancer (86)
Brain cancer (32)
Breast cancer (315)
Cancer (2502)
Cardiovascular disease (211)
Career advice (3535)
Career pathing (34)
CAR-T (178)
Cell therapy (504)
Cervical cancer (22)
Clinical research (73504)
Collaboration (938)
Company closure (2)
Compensation (586)
Complete response letters (30)
COVID-19 (2869)
CRISPR (50)
C-suite (276)
Cystic fibrosis (110)
Data (2391)
Decentralized trials (2)
Denatured (46)
Depression (57)
Diabetes (303)
Diagnostics (6931)
Digital health (21)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (152)
Drug pricing (133)
Drug shortages (33)
Duchenne muscular dystrophy (104)
Earnings (97067)
Editorial (47)
Employer branding (25)
Employer resources (167)
Events (130283)
Executive appointments (793)
FDA (19563)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (837)
Gene editing (125)
Generative AI (36)
Gene therapy (371)
GLP-1 (866)
Government (5176)
Grass and pollen (6)
Guidances (158)
Healthcare (20892)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (155)
Indications (30)
Infectious disease (3034)
Inflammatory bowel disease (159)
Inflation Reduction Act (11)
Influenza (59)
Intellectual property (103)
Interviews (813)
IPO (17835)
IRA (51)
Job creations (5190)
Job search strategy (2861)
Kidney cancer (11)
Labor market (47)
Layoffs (567)
Leadership (24)
Legal (10115)
Liver cancer (82)
Lung cancer (350)
Lymphoma (162)
Machine learning (9)
Management (65)
Manufacturing (374)
MASH (85)
Medical device (14645)
Medtech (14650)
Mergers & acquisitions (22457)
Metabolic disorders (814)
Multiple sclerosis (90)
NASH (23)
Neurodegenerative disease (120)
Neuropsychiatric disorders (34)
Neuroscience (2135)
NextGen: Class of 2025 (7682)
Non-profit (5082)
Now hiring (41)
Obesity (434)
Opinion (276)
Ovarian cancer (84)
Pain (105)
Pancreatic cancer (91)
Parkinson's disease (165)
Partnered (25)
Patents (261)
Patient recruitment (119)
Peanut (51)
People (65348)
Pharmaceutical (143)
Pharmacy benefit managers (22)
Phase I (22684)
Phase II (31918)
Phase III (24042)
Pipeline (1420)
Policy (181)
Postmarket research (3552)
Preclinical (10241)
Press Release (72)
Prostate cancer (115)
Psychedelics (38)
Radiopharmaceuticals (271)
Rare diseases (439)
Real estate (7392)
Recruiting (75)
Regulatory (26844)
Reports (58)
Research institute (2658)
Resumes & cover letters (649)
Rett syndrome (6)
RNA editing (5)
RSV (50)
Schizophrenia (84)
Series A (144)
Series B (94)
Service/supplier (30)
Sickle cell disease (59)
Special edition (20)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4295)
State (2)
Stomach cancer (16)
Supply chain (76)
Tariffs (57)
The Weekly (83)
Vaccines (825)
Venture capitalists (45)
Weight loss (308)
Women's health (41)
Worklife (20)
Date
Today (188)
Last 7 days (1032)
Last 30 days (3327)
Last 365 days (35591)
2025 (13023)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (61)
Alaska (7)
Arizona (270)
Arkansas (14)
Asia (50179)
Australia (8837)
California (6722)
Canada (2113)
China (582)
Colorado (291)
Connecticut (309)
Delaware (170)
Europe (115150)
Florida (985)
Georgia (229)
Hawaii (1)
Idaho (64)
Illinois (642)
India (31)
Indiana (347)
Iowa (12)
Japan (178)
Kansas (113)
Kentucky (28)
Louisiana (15)
Maine (71)
Maryland (996)
Massachusetts (5146)
Michigan (254)
Minnesota (435)
Mississippi (2)
Missouri (92)
Montana (31)
Nebraska (26)
Nevada (70)
New Hampshire (70)
New Jersey (1886)
New Mexico (31)
New York (1888)
North Carolina (1153)
North Dakota (9)
Northern California (2897)
Ohio (226)
Oklahoma (15)
Oregon (48)
Pennsylvania (1475)
Puerto Rico (14)
Rhode Island (36)
South America (1653)
South Carolina (26)
South Dakota (1)
Southern California (2491)
Tennessee (108)
Texas (1011)
United States (25680)
Utah (199)
Virginia (177)
Washington D.C. (72)
Washington State (618)
West Virginia (3)
Wisconsin (72)
There are 847,484 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug pricing
Trump’s Drug Pricing Order ‘More Bark Than Bite’
While industry groups decried the Trump administration’s new drug pricing order, analysts say it lacked details and the teeth to make a major impact without an act of Congress.
May 12, 2025
·
5 min read
·
Annalee Armstrong
Press Releases
EvoSelect®, A Machine Learning Enzyme Engineering Tool is Released!
May 12, 2025
·
3 min read
Layoffs
Lexeo Trims 15% of Workforce, Shifts Focus to Lead Cardiac Programs
Lexeo wants to more quickly move investigational gene therapy LX2006 into a registrational study and hopes for a potential efficacy readout in 2027.
May 12, 2025
·
1 min read
·
Angela Gabriel
Layoff Tracker
IGM Axes 80% of Workforce
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
May 12, 2025
·
200 min read
·
BioSpace Editorial Staff
Drug pricing
White House Unwraps Massive Drug Pricing Policy, Touching All Corners of Pharma
The package revives President Donald Trump’s much-maligned Most Favored Nations rule but goes further into the private markets and beyond, leveraging the patent system, drug importation and more.
May 12, 2025
·
6 min read
·
Annalee Armstrong
Press Releases
Brain Cancer Canada Grants McGill University $100,000 to Advance Pediatric Brain Cancer Research
May 12, 2025
·
3 min read
Press Releases
EmVenio Research wins Best Clinical Trial Company award at 2025 ViE Awards
May 12, 2025
·
2 min read
Press Releases
MaxisIT Evolves to Maxis AI, Launches Enterprise-Ready Agentic AI Platform to Transform Clinical Trials in Pharmaceutical and Life Sciences Industry
May 12, 2025
·
3 min read
Press Releases
Number of Shares and Voting Rights of Innate Pharma as of May 5, 2025
May 12, 2025
·
4 min read
Press Releases
Fortrea Reports First Quarter 2025 Results
May 12, 2025
·
17 min read
1 of 84,749
Next
